If you were wondering whether to buy or sell after a 162% run in two days, look for a drop on the open from the two-day wonder stock, Threshold Pharmaceuticals (NASDAQ: THLD) after the rally from the biotech firm’s announcement that it was partnering with German drug maker Merck. The rally has ...
7
FEB
FEB
0
Share
